A first in Canada: generic version of pirfenidone

Sandoz Canada announced the launch of ^PrSandoz^® Pirfenidone tablets, a generic equivalent to ^PrEsbriet^® manufactured by hoffmann-La Roche. Pirfenidone is indicated in the treatment for idiopathic pulmonary fibrosis in adults. Sandoz is the first manufacturer to launch the generic version of ^PrEsbriet^® in Canada, thereby helping to generate savings for patients and public and private drug insurance plan providers.

Mainly sold at the community pharmacy level, the 267 mg tablets are available in two different bottle sizes, 21 and 270 tablets. The 801 mg tablets are also available in a bottle of 90 tablets.

Healthcare professionals and patients treated with ^PrSandoz^® Pirfenidone can now count on Sandoz Continum™ Patient Support Program for educational tools, reimbursement and financial assistance where permitted.